Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma

ABSTRACT: Hepatocellular carcinoma (HCC) remains to a common cause of tumor mortality

SUBMITTER: Dai X 

PROVIDER: S-EPMC7432969 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature